Search Within

Martin Stuart Tallman

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (74)
  2. Journal Article (61)
  3. Research Letter (2)
  4. Book Section (1)
  5. Guidelines (1)
  6. Review (1)
Groups
  1. Adult Leukemia (140)
  2. Center for Hematologic Malignancies (140)
  3. Department of Medicine (140)
  4. GSK Faculty (140)
  5. Hematologic Malignancies, Division of (140)
  6. Human Oncology and Pathogenesis Program (140)

More Groups

People
  1. Ross Levine (131)
  2. Omar Abdel-Wahab (51)
  3. Maria Arcila (30)
  4. Eytan Stein (29)
  5. Minal Patel (24)
  6. Raajit Rampal (24)

More People

Years
  1. 2024 (1)
  2. 2023 (5)
  3. 2022 (7)
  4. 2021 (7)
  5. 2020 (13)
  6. 2019 (11)

More Years

Publications
  1. Blood (70)
  2. Haematologica (8)
  3. Blood Advances (6)
  4. Leukemia Research (6)
  5. Cancer Research (5)
  6. Cancer Discovery (4)

More Publications

Publishers
  1. American Society of Hematology (76)
  2. Nature Publishing Group (14)
  3. American Association for Cancer Research (9)
  4. Ferrata Storti Foundation (8)
  5. Cell Press (6)
  6. Elsevier Ltd (6)

More Publishers

Results (140)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Msi2 maintains the MLL leukemia stem cell regulatory program
    Meeting Abstract

    Park, S. M.; Gonen, M.; Vu, L. P.; Minuesa, G.; Tivnan, P.; Barlowe, T.; Taggart, J.; Lu, Y. H.; Deering, R. P.; Hacohen, N.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Vemurafenib has potent antitumor activity in patients with relapsed/refractory BRAF mutant hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Kim, E.; Saven, A.; Wadleigh, M.; Stone, R. M.; Barrientos, J. C.; Rai, K. R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • High dose daunorubicin improves survival in AML up to age 60, across all cytogenetic Risk groups including patients with unfavorable cytogenetic risk, and FLT3-ITD mutant AML: Updated analyses from Eastern Cooperative Oncology trial E1900
    Meeting Abstract

    Luskin, M. R.; Lee, J. W.; Fernandez, H. F.; Lazarus, H. M.; Rowe, J. M.; Tallman, M. S.; Paietta, E. M.; Litzow, M.; Abdel-Wahab, O.; Patel, J. P.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Results of the ECOG E1900 trial in younger adults with AML using an event free survival endpoint are concordant with results based on overall survival: Potential for a surrogate endpoint to facilitate rapid approval of therapies in AML
    Meeting Abstract

    Luskin, M. R.; Lee, J. W.; Fernandez, H. F.; Lazarus, H. M.; Rowe, J. M.; Tallman, M. S.; Paietta, E. M.; Litzow, M.; Abdel-Wahab, O.; Patel, J. P.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Genomic analysis of serial samples from CLL patients identifies clonal events associated with disease progression
    Meeting Abstract

    Gardner, J. R.; Nahas, M.; He, J.; Aumann, S.; Gonen, M.; Patel, M.; Knapp, K. M.; Palomba, M. L.; Yelensky, R.; Donahue, A. L.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Minimal residual disease assessment by flow cytometry in AML is an independant prognostic factor even after adjusting for cytogenetic/molecular abnormalities
    Meeting Abstract

    Ganzel, C.; Sun, Z. X.; Gonen, M.; Patel, J. P.; Abdel-Wahab, O.; Fernandez, H. F.; Rowe, J. M.; Tallman, M. S.; Levine, R. L.; Paietta, E. M.
    Blood (2014)

    Fulltext@MSK | Save
  • Utility of combined DNA and RNA next generation sequencing in leukemias for identification of prognostic and therapeutically relevant genomic alterations in clinical practice
    Meeting Abstract

    Coombs, C. C.; Viny, A. D.; He, J.; Kobos, R.; Lipson, D.; Shukla, N.; Knapp, K. M.; Otto, G.; Abdel-Wahab, O.; Stein, E. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Hyperactive PTPN11 mutations alters leukemic stem cell frequency through Mcl-1 overexpression
    Meeting Abstract

    Chen, L. L.; Chen, W.; Mysliwski, M.; Serio, J.; Ropa, J.; Abulwerdi, F.; Chan, R. J.; Patel, J. P.; Tallman, M. S.; Paietta, E. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia
    Journal Article

    Rampal, R.; Alkalin, A.; Madzo, J.; Vasanthakumar, A.; Pronier, E.; Patel, J.; Li, Y.; Ahn, J.; Abdel-Wahab, O.; Shih, A.; more...
    Cell Reports (2014)

    Fulltext@MSK | Save
  • Brafv600e mutations in hematopoietic stem cells of hairy cell leukemia patients suggests a stem cell origin
    Meeting Abstract

    Chung, S. S.; Kim, E.; Park, J. H.; Chung, Y. R.; Feldstein, J.; Hu, W.; Rampal, R.; Patel, M.; Kim, M. K.; Huberman, K.; more...
    Haematologica (2014)

    Fulltext@MSK | Save